A randomized trial of metronidazole in a single 2 g dose versus 500 mg twice daily for 7 days for the treatment of trichomoniasis in women

BACKGROUND: Trichomonias is the most common non-viral STI among women worldwide and is associated with serious reproductive morbidity, poor birth outcomes and amplified HIV transmission. Single-dose metronidazole therapy has been the treatment of choice for over three decades. There is mounting evid...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet Infect Dis
Main Authors: Kissinger, Patricia, Muzny, Christina A., Mena, Leandro, Lillis, Rebecca A., Schwebke, Jane R., Beauchamps, Laura, Taylor, Stephanie N., Schmidt, Norine, Myers, Leann, Augostini, Peter, Secor, William E., Bradic, Martina, Carlton, Jane M., Martin, David H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6279510/
https://ncbi.nlm.nih.gov/pubmed/30297322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(18)30423-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados